Skyscape Web Viewer : TNM Cancer Staging Manual : Main Index

View All
Factor VIII Uvea: Choroidal and Ciliary Body Melanomas Uvea: Iris Melanomas
Fallopian tube anatomic sites clinical classification histologic typing histology and grade imaging pathological classification primary site(s) primary tumors (T) prognostic factors regional lymph nodes risk assessment models surgical management
Federation Internationale de Gynecologie et d'Obstetrique (FIGO)
Female pattern disease
Female Urethra
FFA
FIGURE CERVIX UTERI-ANATOMY
Five-year overall survival of 2,013 patients with MCC in the NCDB with clinical staging only for local disease (cN0 pNx; i
Five-year overall survival of 2,465 MCC patients with regional lymph node metastases in the NCDB, stratified by tumor burden and primary tumor status: clinically and radiologically occult nodal metastasis (N1a) detected by SLNB or otherwise; clinically or radiologically detected and pathologically confirmed nodal metastasis (N1b) with or without the presence of a primary tumor; and in-transit disease (N2)
Five-year overall survival of 5,371 patients with MCC in the NCDB with pathological staging, including 1,502 patients in stage group I, 493 in stage group IIA, 127 in stage group IIB, 1,536 in stage group IIIA, 929 in stage group IIIB, and 784 in stage group IV
Five-year overall survival of 6,127 patients with local MCC only (clinically and , if known, pathologically node negative) in the NCDB, stratified by T category ( 2 cm, T1; 2 cm, T2/3; involving fascia, muscle, cartilage, or bone, T4)
Five-year overall survival of 9,387 patients with MCC in the NCDB, stratified by local, regional nodal, and distant metastatic disease
Flexner-Wintersteiner rosettes
Fludarabine
Fluorescein Retinoblastoma Retinoblastoma Uvea: Choroidal and Ciliary Body Melanomas Uvea: Iris Melanomas
Fluorescence in situ hybridization (FISH)
Fluorodeoxyglucose positron emission tomography (18F-FDG PET) scans Adrenal Cortical Carcinoma Breast Kidney Soft Tissue Sarcoma Unusual Histologies and Sites
Fluorouracil Conjunctival Carcinoma Exocrine Pancreas
Fluorouracil (5-Fu)
FNCLCC
Focal seizures
Folate Breast Breast: Ductal Carcinoma in situ
Follicular lymphoma FLIPI GELF criteria Ocular Adnexal Lymphoma prognostic factors, stage grouping
Follicular Lymphoma International Prognostic Index (FLIPI) Non-Hodgkin Lymphoma: Follicular Lymphoma Non-Hodgkin Lymphoma: Mantle Cell Lymphoma Non-Hodgkin Lymphoma: Marginal Zone Lymphoma Ocular Adnexal Lymphoma
For appendicular skeleton, trunk, skull, and facial bones, T1 is defined as tumor 8 cm or less in greatest dimension
For appendicular skeleton, trunk, skull, and facial bones, T2 is defined as tumor more than 8 cm in greatest dimension
For appendicular skeleton, trunk, skull, and facial bones, T3 is defined as discontinuous tumors in the primary bone site
For carcinomas T1a is tumor limited to the endometrium or invading less than half the myometrium
For carcinomas T1b is tumor invading one half or more of the myometrium
For carcinomas T2 is tumor invading the stromal connective tissue of the cervix but not extending beyond the uterus

NDX